• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Preparation and evaluation of gelatin/sodium carboxymethyl cellulose polyelectrolyte complex microparticles for controlled delivery of isoniazid.制备和评价明胶/羧甲基纤维素钠聚电解质复合微球用于异烟肼的控制释放。
AAPS PharmSciTech. 2009;10(4):1412-9. doi: 10.1208/s12249-009-9344-9. Epub 2009 Nov 24.
2
Microencapsulation of isoniazid in genipin-crosslinked gelatin-A-κ-carrageenan polyelectrolyte complex.微囊化异烟肼在京尼平交联明胶-A-κ-卡拉胶聚电解质复合物中的应用。
Drug Dev Ind Pharm. 2010 Jan;36(1):56-63. doi: 10.3109/03639040903061355.
3
Novel pH- and temperature-responsive blend hydrogel microspheres of sodium alginate and PNIPAAm-g-GG for controlled release of isoniazid.新型 pH 和温度响应性海藻酸钠和 PNIPAAm-g-GG 共混水凝胶微球用于异烟肼的控制释放。
AAPS PharmSciTech. 2012 Dec;13(4):1147-57. doi: 10.1208/s12249-012-9838-8. Epub 2012 Sep 6.
4
Formulation and optimization of alkaline extracted ispaghula husk microparticles of isoniazid - in vitro and in vivo assessment.碱性提取伊克多因微球的配方优化及其体内外评价。
J Microencapsul. 2011;28(6):472-82. doi: 10.3109/02652048.2011.580861. Epub 2011 May 12.
5
Alginate microspheres of isoniazid for oral sustained drug delivery.用于口服持续给药的异烟肼海藻酸盐微球。
Int J Pharm. 2007 Apr 4;334(1-2):71-7. doi: 10.1016/j.ijpharm.2006.10.024. Epub 2006 Oct 21.
6
Interpenetrating polymer network blend microspheres of chitosan and hydroxyethyl cellulose for controlled release of isoniazid.壳聚糖和羟乙基纤维素互穿聚合物网络共混微球用于异烟肼的控制释放。
Int J Biol Macromol. 2010 Aug 1;47(2):171-9. doi: 10.1016/j.ijbiomac.2010.05.003. Epub 2010 May 13.
7
Novel multiparticulate pH triggered delayed release chronotherapeutic drug delivery of celecoxib-β-cyclodextrin inclusion complexes by using Box-Behnken design.采用 Box-Behnken 设计的塞来昔布-β-环糊精包合物新型多颗粒 pH 触发迟释时控药物传递系统。
Eur J Pharm Sci. 2020 Apr 15;146:105254. doi: 10.1016/j.ejps.2020.105254. Epub 2020 Feb 2.
8
Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.含利福平的异烟肼-明胶结合微球用于治疗结核病。
J Pharm Pharmacol. 2013 Sep;65(9):1302-11. doi: 10.1111/jphp.12094. Epub 2013 Jul 5.
9
Gelatin/carboxymethyl cellulose based stimuli-responsive hydrogels for controlled delivery of 5-fluorouracil, development, in vitro characterization, in vivo safety and bioavailability evaluation.明胶/羧甲基纤维素基刺激响应水凝胶用于 5-氟尿嘧啶的控制释放:制备、体外表征、体内安全性和生物利用度评价。
Carbohydr Polym. 2021 Apr 1;257:117617. doi: 10.1016/j.carbpol.2021.117617. Epub 2021 Jan 16.
10
Controlled release of clozapine through chitosan microparticles prepared by a novel method.通过一种新方法制备的壳聚糖微粒实现氯氮平的控释。
J Control Release. 2004 Apr 28;96(2):245-59. doi: 10.1016/j.jconrel.2004.01.025.

引用本文的文献

1
Biopolymer Hydrogel Scaffolds Containing Doxorubicin as A Localized Drug Delivery System for Inhibiting Lung Cancer Cell Proliferation.含有阿霉素的生物聚合物水凝胶支架作为抑制肺癌细胞增殖的局部给药系统
Polymers (Basel). 2021 Oct 17;13(20):3580. doi: 10.3390/polym13203580.
2
Recent Developments of Carboxymethyl Cellulose.羧甲基纤维素的最新进展
Polymers (Basel). 2021 Apr 20;13(8):1345. doi: 10.3390/polym13081345.
3
Novel Approaches for the Treatment of Pulmonary Tuberculosis.治疗肺结核的新方法。
Pharmaceutics. 2020 Dec 10;12(12):1196. doi: 10.3390/pharmaceutics12121196.
4
Extraction of Hydroxyapatite Nanostructures from Marine Wastes for the Fabrication of Biopolymer-Based Porous Scaffolds.从海洋废弃物中提取羟基磷灰石纳米结构,用于制备基于生物聚合物的多孔支架。
Mar Drugs. 2019 Dec 27;18(1):26. doi: 10.3390/md18010026.
5
Comparison between gelatin/carboxymethyl cellulose and gelatin/carboxymethyl nanocellulose in tramadol drug loaded capsule.曲马多载药胶囊中明胶/羧甲基纤维素与明胶/羧甲基纳米纤维素的比较。
Heliyon. 2019 Sep 3;5(9):e02404. doi: 10.1016/j.heliyon.2019.e02404. eCollection 2019 Sep.
6
Development and In Vitro Release of Isoniazid and Rifampicin-Loaded Bovine Serum Albumin Nanoparticles.载异烟肼和利福平的牛血清白蛋白纳米粒的制备及其体外释放。
Med Sci Monit. 2018 Jan 24;24:473-478. doi: 10.12659/msm.905581.
7
Interpolyelectrolyte complexes of Eudragit® EPO with hypromellose acetate succinate and Eudragit® EPO with hypromellose phthalate as potential carriers for oral controlled drug delivery.以醋酸琥珀酸羟丙甲纤维素和邻苯二甲酸羟丙甲纤维素为潜在载体的Eudragit® EPO聚电解质复合物用于口服控释给药。
AAPS PharmSciTech. 2015 Aug;16(4):878-88. doi: 10.1208/s12249-014-0252-2. Epub 2015 Jan 16.

本文引用的文献

1
Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery.卡维地洛海藻酸钠粘膜粘附微球的研制、优化及鼻腔给药的体外评价。
J Microencapsul. 2009 Aug;26(5):432-43. doi: 10.1080/02652040802456726.
2
The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.纳米颗粒药物递送系统在结核病化疗中的潜在优势。
Am J Respir Crit Care Med. 2005 Dec 15;172(12):1487-90. doi: 10.1164/rccm.200504-613PP. Epub 2005 Sep 8.
3
Effects of pulmonary surfactant system on rifampicin release from rifampicin-loaded PLGA microspheres.肺表面活性物质系统对载利福平的聚乳酸-羟基乙酸共聚物微球中利福平释放的影响。
Colloids Surf B Biointerfaces. 2005 Sep 25;45(1):1-6. doi: 10.1016/j.colsurfb.2005.06.014.
4
Controlled release of clozapine through chitosan microparticles prepared by a novel method.通过一种新方法制备的壳聚糖微粒实现氯氮平的控释。
J Control Release. 2004 Apr 28;96(2):245-59. doi: 10.1016/j.jconrel.2004.01.025.
5
Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers.海藻酸盐-壳聚糖微球作为抗结核药物载体的化疗潜力。
J Antimicrob Chemother. 2004 Apr;53(4):635-40. doi: 10.1093/jac/dkh139. Epub 2004 Mar 3.
6
Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.用于实验性结核病的基于聚(DL-丙交酯-共-乙交酯)纳米颗粒的可吸入持续给药系统
J Antimicrob Chemother. 2003 Dec;52(6):981-6. doi: 10.1093/jac/dkg477. Epub 2003 Nov 12.
7
Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis.口服含异烟肼、利福平及吡嗪酰胺的聚(丙交酯-乙交酯)微粒对实验性结核病的化疗潜力
Antimicrob Agents Chemother. 2003 Sep;47(9):3005-7. doi: 10.1128/AAC.47.9.3005-3007.2003.
8
Chitosan-based gastrointestinal delivery systems.基于壳聚糖的胃肠道给药系统。
J Control Release. 2003 Apr 29;89(2):151-65. doi: 10.1016/s0168-3659(03)00126-3.
9
Microspheres of alginate-chitosan containing isoniazid.含有异烟肼的海藻酸钠-壳聚糖微球
J Microencapsul. 2003 Mar-Apr;20(2):145-52.
10
Alginate in drug delivery systems.药物递送系统中的藻酸盐。
Drug Dev Ind Pharm. 2002 Jul;28(6):621-30. doi: 10.1081/ddc-120003853.

制备和评价明胶/羧甲基纤维素钠聚电解质复合微球用于异烟肼的控制释放。

Preparation and evaluation of gelatin/sodium carboxymethyl cellulose polyelectrolyte complex microparticles for controlled delivery of isoniazid.

机构信息

Department of Chemical Sciences, Tezpur University, Napaam, 784028, India.

出版信息

AAPS PharmSciTech. 2009;10(4):1412-9. doi: 10.1208/s12249-009-9344-9. Epub 2009 Nov 24.

DOI:10.1208/s12249-009-9344-9
PMID:19937282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2799610/
Abstract

The ratio of gelatin to sodium carboxymethyl cellulose (SCMC) at which maximum yield was obtained was optimized. This optimized ratio of gelatin to SCMC along with other parameters was used to prepare microparticles of different sizes. Vegetable oil was used as emulsion medium. Effect of various factors like amount of surfactant, concentration of polymer on the formation, and size of the microparticles was investigated. These microparticles were used as carrier for isoniazid. Among different cross-linkers, glutaraldehyde was found to be the most effective cross-linker at the temperature and pH at which the reaction was carried out. The loading efficiency and release behavior of loaded microparticles were found to be dependent on the amount of cross-linker used, concentration of drug, and time of immersion. Maximum drug loading efficiency was observed at higher immersion time. The release rate of isoniazid was more at higher pH compared to that of at lower pH. The sizes of the microparticles were investigated by scanning electron microscope. In all the cases, the microparticles formed were found spherical in shape except to those at low stirring speed where they were agglomerated. Fourier transform infrared study indicated the successful incorporation of isoniazid into the microparticles. Differential scanning calorimetry study showed a molecular level dispersion of isoniazid in the microparticles. X-ray diffraction study revealed the development of some crystallinity due to the encapsulation of isoniazid.

摘要

优化了获得最大产率的明胶与羧甲基纤维素钠(CMC)的比例。使用该明胶与 CMC 的最佳比例以及其他参数来制备不同大小的微球。植物油被用作乳化介质。研究了各种因素,如表面活性剂的用量、聚合物浓度对微球形成和大小的影响。这些微球被用作异烟肼的载体。在不同的交联剂中,戊二醛在反应进行的温度和 pH 值下被发现是最有效的交联剂。载药微球的载药效率和释放行为取决于所用交联剂的量、药物的浓度和浸泡时间。在较高的浸泡时间下观察到最大的药物载药效率。与较低 pH 值相比,较高 pH 值下异烟肼的释放速率更高。通过扫描电子显微镜研究了微球的大小。在所有情况下,形成的微球均呈球形,除了在较低搅拌速度下,微球发生团聚。傅里叶变换红外研究表明异烟肼已成功掺入微球中。差示扫描量热法研究表明异烟肼在微球中呈分子水平分散。X 射线衍射研究表明由于异烟肼的包封,出现了一些结晶度。